Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02505919 · ClinicalTrials.gov registry record · NA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A NA study, sponsored by PROCEPT BioRobotics.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
NCT02505919 is a NA study that has completed, run by PROCEPT BioRobotics. The registered enrollment target is 184 participants.
The verdict
NCT02505919, a NA study, has completed, sponsored by PROCEPT BioRobotics.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
Study Summary
A prospective multicenter randomized blinded study comparing Aquablation of the prostate with the AQUABEAM System and TURP for the treatment of Lower Urinary Tract Symptoms (LUTS). The primary endpoints for safety and effectiveness were measured at 3 and 6 months, respectively, and subjects were followed out to 5 years to collect long-term clinical data.
Interventions
- DEVICE AQUABEAM System
- PROCEDURE Transurethral Resection of the Prostate (TURP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2015-10-30 |
| Est. Completion | 2021-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02505919
The ClinicalTrials.gov registry entry for NCT02505919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PROCEPT BioRobotics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AQUABEAM System is the first listed.
NCT02505919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02505919 about?
NCT02505919 is a clinical study titled "Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)". A prospective multicenter randomized blinded study comparing Aquablation of the prostate with the AQUABEAM System and TURP for the treatment of Lower Urinary Tract Symptoms (LUTS). The primary endpoints for safety and effectiveness were measured at 3 and 6 months, respectively, and subjects were fol...
What is the current status of trial NCT02505919?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2015-10-30. Estimated completion is 2021-12-16.
What interventions are being tested in trial NCT02505919?
The interventions under investigation include: AQUABEAM System (DEVICE), Transurethral Resection of the Prostate (TURP) (PROCEDURE).
Who is sponsoring clinical trial NCT02505919?
This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.